Table 1 Overview of the conventional IMRT and MCO-plan quality scores and the inter-rater reliability
Technique | ||||
|---|---|---|---|---|
Conventional IMRT | MCO | |||
Item | Mean (SD) | Mean (SD) | p- value | ICC agreement (95% CI) |
1: Dose hot spots in PTVboost | 4.7 (0.5) | 4.7 (0.5) | 1.00 | 0.26 (−0.36 – 0.6) |
2: Dose hotspots in PTVprophylactic | 4.4 (0.9) | 4.6 (0.5) | 0.15 | 0.51 (0.28 – 0.79) |
3: Dose cold spots in PTVboost | 3.9 (0.9) | 3.5 (0.9) | 0.01 | 0.57 (0.22 – 0.77) |
4: Dose cold spots in PTVprophylactic | 4.0 (1.2) | 3.9 (1.1) | 0.45 | 0.70 (0.45 – 0.84) |
5: Conformity of 95% isodose around PTVboost | 3.8 (1.0) | 3.5 (0.8) | 0.11 | 0.19 (−0.45 – 0.56) |
6: Conformity of 95% isodose around PTVprophylactic | 4.0 (1.1) | 3.7 (1.1) | 0.07 | 0.61 (0.29 – 0.79) |
7: Maximum dose to spinal cord | 4.9 (0.5) | 5.0 (0.2) | 0.28 | 0.83 (0.70 – 0.91) |
8: Parotid gland dose | 4.4 (0.7) | 4.3 (0.7) | 0.62 | 0.67 (0.40 – 0.82) |
9: Dose in unspecified tissue | 4.0 (0.8) | 3.7 (0.8) | 0.07 | 0.28 (−0.31 – 0.61) |
10: General plan quality | 3.8 (1.2) | 3.6 (1.1) | 0.29 | 0.44 (−0.33 – 0.69) |
Total | 41.7 (6.4) | 40.4 (5.4) | 0.15 | 0.65 (0.57 – 0.71) |